Clinical Trials Directory

Trials / Completed

CompletedNCT06385912

Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer

Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer: a Multicenter Real-world Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,090 (actual)
Sponsor
Tongji Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The study aims to investigate the prognostic and postoperative complication relevance of lymphadenectomy in advanced epithelial ovarian cancer patients who received neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS). The main question it aims to answer is: Does systematic lymphadenectomy during interval debulking surgery have a significant impact on survival in patients with advanced epithelial ovarian cancer who have received neoadjuvant chemotherapy? The progression-free survival (PFS), overall survival (OS), and postoperative complication were compared between the lymphadenectomy and no lymphadenectomy groups to answer the question.

Detailed description

The study aims to investigate the prognostic and postoperative complication relevance of lymphadenectomy in advanced epithelial ovarian cancer patients who received neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS). The study included patients with histologically confirmed advanced epithelial ovarian cancer who received IDS at seven tertiary hospitals in China from 2006 to 2021. The progression-free survival (PFS), overall survival (OS), and postoperative complication were compared between the lymphadenectomy and no lymphadenectomy groups. Propensity score matching (PSM) and overlapping weight (OW) analyses were performed to minimize selection bias.

Conditions

Interventions

TypeNameDescription
PROCEDURElymphadenectomySystematic pelvic and para-aortic lymphadenectomy during IDS in lymphadenectomy group

Timeline

Start date
2006-07-01
Primary completion
2021-02-10
Completion
2021-02-10
First posted
2024-04-26
Last updated
2024-04-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06385912. Inclusion in this directory is not an endorsement.